Phase II trial of the novel antiplatelet agent, SCH 530348, in Japanese patients with non-ST segment elevation acute coronary syndromes (NSTE ACS) - Goto, S; Yamaguchi, T; Ikeda, Y (Eur Heart J, 2008)
P4767.